Surreal illustration of coffee beans transforming into urine droplets, symbolizing the measurement of caffeine biomarkers in urine.

Caffeine Check: How Accurate Are Your Intake Estimates?

"New research compares a 24-hour caffeine recall tool with urinary biomarkers to assess caffeine intake among young adults, revealing insights into consumption patterns and validation methods."


Caffeine is a widely consumed stimulant, and its presence is increasingly noted in various products marketed towards young adults. With this rise in consumption, accurately measuring caffeine intake becomes crucial, yet existing tools often fall short, especially among younger populations.

To bridge this gap, researchers developed the 24-Hour Caffeine Intake Recall (CIR-24), modeled after the Automated Self-Administered 24-Hour Dietary Assessment Tool. This tool uses a brand-specific database of caffeine-containing foods, beverages, and supplements to estimate caffeine consumption over the previous 24 hours.

A new study has evaluated the accuracy of the CIR-24 by comparing it with caffeine concentration biomarkers in urine and a caffeinated beverage intake frequency screener (CBQ). The research offers insights into the effectiveness of different assessment methods for gauging caffeine consumption in young adults.

AI Search Multiple angles on this topic

How Common Caffeine Use Really Is

Caffeine is one of the most widely consumed substances in the world, yet dependable, population-level figures on exactly how much people take in are surprisingly hard to pin down. Surveys and consumer-reports data point to steady if uneven growth in coffee, energy drink, and soda consumption, but estimates vary across countries, age groups, and survey methods. Because intake is typically self-reported, totals likely understate or overstate true consumption depending on how people estimate serving sizes and product strengths. The practical upshot is that most published statistics should be treated as directional guidance rather than precise measurements.

How Intake Gets Estimated, and Where It Falls Short

Most caffeine-intake estimates rely on self-reported recall, food-frequency questionnaires, or national consumption surveys, often cross-referenced against published caffeine-content tables. These methods are convenient and reproducible, but they carry well-known limitations. Reported portion sizes are frequently inaccurate, caffeine contents can vary widely across brands, brews, and preparation styles, and respondents rarely account for serving variability between drinks. As a result, the conventional approach can systematically misestimate an individual's true intake, which matters when the same estimates are used to judge whether someone is within safe levels.

From Tea Leaves to Energy Drinks: A Brief History

Caffeine has been one of the most popular drugs throughout history, beginning with tea leaves, then coffee, sodas, and now energy drinks, with caffeinated beverages constantly adapting to the population's needs. Despite coffee dominating modern drink consumption, tea was the original popular caffeinated beverage, with Chinese tea cultivation beginning around 2700 B.C. and the beverage then spreading around the world. The spread of caffeine plants thousands of years before the 20th century helped establish caffeine-based culture globally, giving rise to differing styles of coffee-making and a wide variety of pot types. Today caffeine is recognized as a natural stimulant found in coffee, tea, chocolate, and guarana, with a history spanning everything from ancient rituals to modern science-backed energy boosts.

Decoding the Study: Comparing Recall with Reality

Surreal illustration of coffee beans transforming into urine droplets, symbolizing the measurement of caffeine biomarkers in urine.

The study involved 79 young adults aged 18 to 29, who provided 24-hour urine samples and completed both the CIR-24 and CBQ. Researchers then quantified caffeine and eight caffeine metabolites from the urine samples using advanced techniques like high-performance liquid chromatography-polarity switching electrospray ionization-tandem quadrupole mass spectrometry with stable isotope-labeled internal standards.

Statistical analyses were performed to determine the correlation between the self-report tools and caffeine biomarkers. Pearson correlations and weighted κ coefficients were calculated to assess the linear associations and quartile ranking concordance.

  • The CIR-24 showed a significant positive association with all caffeine biomarkers (rp=0.28 to 0.52, κ=0.39 to 0.59).
  • The CBQ was also significantly positively associated with most biomarkers (rp=0.21 to 0.40, k=0.32 to 0.45), though slightly less consistently.
  • Notably, the CIR-24 yielded a higher mean intake of caffeine compared to the CBQ. There was strong linear correlation between the CIR-24 and CBQ (rp=0.60, P<0.001), but only moderate agreement in absolute caffeine consumed (t=2.83, P=0.006); quartile ranking concordance was 0.44 (P<0.001).
  • Across all biomarkers, the CIR-24 performed better than the CBQ in both linear correlation and quartile ranking.
AI Search Multiple angles on this topic

What Recent Studies Keep Finding About Young Consumers

Recent research points to age-dependent effects of caffeine: although caffeine intake is associated with reduced adiposity in adults, recent studies suggest the opposite pattern in children, according to work published in Nature. Energy drink consumption has risen over the past 10-15 years, yet studies describing the effects of caffeine and caffeinated beverages show confusing results, leading researchers to argue that the available facts need regular summarization. Adolescents and young adults typically get caffeine from coffee, tea, and energy drinks, with energy drinks flagged as a potential health risk because of their caffeine content. A February 2026 study in the journal Cogent, titled "To brew or not to brew," is exploring whether consumption motivations influence how caffeine affects stress, anxiety, and depression in young adults, a population seen as especially vulnerable to both high caffeine use and mental health challenges.

The Evidence Against Caffeine Is Messier Than Headlines Suggest

A November 2021 review that analyzed more than 156 scientific papers on caffeine and caffeinated beverages in children, adolescents, and young adults concluded that studies show confusing results, underscoring the need to regularly summarize the facts in more detail. Critics also question the causal case, asking whether regulations preventing the sale of caffeinated beverages to children are justified when almost all research linking caffeine to youth developmental outcomes is merely correlational. Prospective studies remain rare, but recent evidence suggests caffeine use affects adjustment among young adolescents and that both caffeine use and daytime sleepiness may contribute to conduct problem trajectories. Even so, researchers note that some data on energy drinks involve consumption combined with alcohol among adolescents and young people, further complicating efforts to isolate caffeine's effects.

Adults' Data, Kids' Drinks

A 2019 review of caffeine trends, safety, and recommendations notes that caffeine use is common in children and adolescents, but that safe-consumption recommendations are based on decades-old data collected exclusively in adults. The increased availability of caffeine-containing products and concerted marketing aimed at children and adolescents has driven interest in understanding caffeine's physiological, behavioral, and psychological effects. Comparative pharmacokinetic work illustrates another layer of the problem: a study of caffeine administered rapidly or slowly in coffee that was chilled or hot, versus a chilled energy drink, in healthy young adults shows that how a drink is consumed and the beverage form itself can shape caffeine's effects. These differences matter because one-size-fits-all estimates of how a drink will hit the body may not transfer cleanly from adults to young users or across beverage types.

These findings suggest that while both tools can capture caffeine intake reasonably well, the CIR-24 demonstrates stronger agreement with urinary biomarkers, making it a promising tool for evaluating caffeine intake among young adults.

Key Takeaways and Future Directions

The study confirms that both the CIR-24 and CBQ perform reasonably well in capturing caffeine intake when compared with urinary biomarkers. However, the CIR-24 showed stronger agreement, suggesting it is a more accurate tool for assessing daily caffeine consumption.

AI Search Multiple angles on this topic

What the Evidence Adds Up To

Taken together, the research base supports a cautious, age-sensitive view of caffeine rather than a blanket verdict for or against it. Adults appear to tolerate moderate intake well, but the same assumptions do not clearly hold for children and adolescents, where the evidence is thinner and partly conflicting. The recurring theme across studies is uncertainty: self-reported intake is imprecise, effect sizes vary, and much of the developmental research is correlational. Until stronger prospective data exist, the most defensible position is probably to treat caffeine estimates and associated health claims as provisional and in need of continued scrutiny.

A Growing Market and a Data Gap

Industry tracking shows the global energy drink market reached $98.4 billion in 2026, with 31% of teens consuming energy drinks weekly and the FDA setting a safe adult caffeine threshold at 400 mg per day, according to a 2026 statistics report. Yet the recommendations that guide safe consumption are based on decades-old data collected exclusively in adults, even as caffeine use becomes common in children and adolescents amid increased availability and marketing. That gap between a fast-growing market and an adult-centric evidence base suggests the next frontier is research specifically designed around young consumers. Stats compilations such as WorldMetrics' verified 2026 caffeine consumption data point to growing demand for accurate, current figures that can keep pace with product innovation.

Who Is Most Vulnerable, and Why It's Hard to Protect Them

A comprehensive review of the safety of ingested caffeine singles out certain populations as particularly vulnerable to the negative effects of caffeine consumption: pregnant and lactating women, children and adolescents, young adults, and people with underlying heart or other health conditions, such as mental illness. The presence of underlying conditions can change both the risks and the tolerable dose, which complicates any uniform guideline. Because mainstream recommendations were built around healthy adults, translating them to these groups requires assumptions that the evidence base does not fully support. That mismatch represents a systemic challenge for regulators, clinicians, and manufacturers who must set expectations without population-specific data.

What Intake Estimates Mean for Real Lives

Behind every estimate is a person making everyday decisions about coffee, tea, soda, and energy drinks, which is where the accuracy question becomes genuinely consequential. If someone's self-reported intake is off by a large margin, they might unknowingly drift toward amounts associated with sleep disruption, anxiety, or other adverse effects, especially during growth or pregnancy. Individual tolerance and lifestyle factors vary too, so a number that is harmless for one person may be meaningful for another. Given the uncertainty in both measurement and effect, the most honest framing for readers is probably awareness rather than alarm, and a reminder to treat any single intake figure as a rough guide rather than a precise verdict.

For those looking to monitor their caffeine intake, especially young adults, the CIR-24 appears to be a reliable method. It accounts for a broader range of caffeine sources, including foods and supplements, which are often missed by other tools.

Future research could focus on automating the data coding process of the CIR-24 to enhance its usability. Additionally, examining the tool's sensitivity to changes in caffeine consumption over extended periods would further validate its effectiveness.

About this Article -

Written with AI assistance from published research, and reviewed by the Mystum team. See our About page for more information.

This article is based on research published under:

DOI-LINK: 10.1016/j.jand.2018.07.016, Alternate LINK

Title: Evaluation Of A 24-Hour Caffeine Intake Assessment Compared With Urinary Biomarkers Of Caffeine Intake Among Young Adults In Canada

Subject: Nutrition and Dietetics

Journal: Journal of the Academy of Nutrition and Dietetics

Publisher: Elsevier BV

Authors: Lana Vanderlee, Jessica L. Reid, Christine M. White, Rachel B. Acton, Sharon I. Kirkpatrick, Ching-I. Pao, Michael E. Rybak, David Hammond

Published: 2018-12-01

Everything You Need To Know

1

What is the CIR-24, and how does it work to estimate caffeine intake?

The CIR-24, or 24-Hour Caffeine Intake Recall, is designed to estimate caffeine consumption over the previous 24 hours. It is modeled after the Automated Self-Administered 24-Hour Dietary Assessment Tool and uses a brand-specific database of caffeine-containing foods, beverages, and supplements. This level of detail helps in providing a more accurate estimate compared to methods that might rely on broader categories or general recall.

2

How was the accuracy of caffeine intake estimates evaluated in this study?

The accuracy of caffeine intake estimates was assessed by comparing two self-report tools, the CIR-24 and the Caffeinated Beverage intake frequency Questionnaire (CBQ), against caffeine concentration biomarkers found in urine. Researchers used advanced techniques such as high-performance liquid chromatography-polarity switching electrospray ionization-tandem quadrupole mass spectrometry with stable isotope-labeled internal standards to quantify caffeine and eight caffeine metabolites from the urine samples. Statistical analyses, including Pearson correlations and weighted κ coefficients, were performed to determine the correlation between the self-report tools and caffeine biomarkers.

3

Did the 24-Hour Caffeine Intake Recall (CIR-24) tool show a positive association with caffeine levels in the body?

Yes, the CIR-24 showed a significant positive association with all caffeine biomarkers (rp=0.28 to 0.52, κ=0.39 to 0.59). The CBQ was also significantly positively associated with most biomarkers (rp=0.21 to 0.40, k=0.32 to 0.45), though slightly less consistently. Across all biomarkers, the CIR-24 performed better than the CBQ in both linear correlation and quartile ranking.

4

Between the CIR-24 and the Caffeinated Beverage intake frequency Questionnaire (CBQ), which tool was more accurate, and why?

While both the CIR-24 and the CBQ performed reasonably well in capturing caffeine intake, the CIR-24 demonstrated stronger agreement with urinary biomarkers. This suggests the CIR-24 is a more accurate tool for assessing daily caffeine consumption among young adults. The stronger performance of the CIR-24 could be attributed to its detailed, brand-specific database which enables better estimation of caffeine content in consumed products.

5

What specific urinary biomarkers were analyzed, and how were they used to validate caffeine intake?

The urinary biomarkers included caffeine and eight caffeine metabolites, which were quantified using high-performance liquid chromatography-polarity switching electrospray ionization-tandem quadrupole mass spectrometry with stable isotope-labeled internal standards. By measuring these substances in urine, researchers were able to obtain an objective measure of caffeine intake against which the self-reported estimates from the CIR-24 and CBQ tools were compared. This method provides a more reliable measure than self-reporting alone, which can be subject to recall bias or inaccuracies in estimating portion sizes and caffeine content.

Newsletter Subscribe

Subscribe to get the latest articles and insights directly in your inbox.